Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Toru Kojima
Observed name:
T Kojima
Institution:
Saitama Cancer Center
Observed institutions:
Tongji University,
Okayama University,
Okayama University Hospital,
Saitama Cancer Center,
Shanghai Pulmonary Hospital,
Oncolys BioPharma (Japan)
show all 6
ORCID:
0009-0007-5015-2546
Observed ORCID:
0009-0007-5015-2546
OpenAlex ID:
A5020379565
In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus
2006
·
Hiroyuki Kishimoto
, Toru Kojima
, et al.
·
Nature Medicine
·
180
A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression
2012
·
Yasumoto Yamasaki
, Hiroshi Tazawa
, et al.
·
European Journal of Cancer
·
66
Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer
2009
·
Dong Liu
, Toru Kojima
, et al.
·
Molecular Cancer Therapeutics
·
52
In Vivo Biological Purging for Lymph Node Metastasis of Human Colorectal Cancer by Telomerase-Specific Oncolytic Virotherapy
2010
·
Toru Kojima
, Yuichi Watanabe
, et al.
·
Annals of Surgery
·
34
A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
2009
·
Y Watanabe
, T Kojima
, et al.
·
Oncogene
·
34
Telomerase-Specific Virotheranostics for Human Head and Neck Cancer
2009
·
Yuji Kurihara
, Yuichi Watanabe
, et al.
·
Clinical Cancer Research
·
30
Japanese Society for Radiation Oncology Consensus Guidelines of combined intracavitary and interstitial brachytherapy for gynecological cancers
2022
·
Naoya Murakami
, Tatsuya Ohno
, et al.
·
Journal of Radiation Research
·
25
PDF
The hTERT Promoter Enhances the Antitumor Activity of an Oncolytic Adenovirus under a Hypoxic Microenvironment
2012
·
Yuuri Hashimoto
, Hiroshi Tazawa
, et al.
·
PLoS ONE
·
25
PDF
Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
2010
·
Ryo Sakai
, Shunsuke Kagawa
, et al.
·
Molecular Cancer Therapeutics
·
24
A Novel Antiangiogenic Effect for Telomerase-Specific Virotherapy through Host Immune System
2009
·
Yoshihiro Ikeda
, Toru Kojima
, et al.
·
The Journal of Immunology
·
24
PDF
A national survey on the medical physics workload of external beam radiotherapy in Japan
2023
·
Naoki Tohyama
, Hiroyuki Okamoto
, et al.
·
Journal of Radiation Research
·
19
PDF
Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy
2008
·
Masayoshi Hioki
, Shunsuke Kagawa
, et al.
·
International Journal of Cancer
·
17
303. Enhanced Antitumor Efficacy of Telomerase-Selective Oncolytic Adenoviral Agent OBP-401 with Docetaxel: Preclinical Evaluation of Chemovirotherapy
2006
·
Yoshihiro Ikeda
, Toshiya Fujiwara
, et al.
·
Molecular Therapy
·
8
PDF
Patterns of care for brachytherapy in Japan
2023
·
Hitoshi Ikushima
, Noriko Ii
, et al.
·
Journal of Radiation Research
·
6
PDF
Current status and issues with the dosimetric assay of iodine-125 seed sources at medical facilities in Japan: a questionnaire-based survey
2023
·
Toru Kojima
, Shinji Kawamura
, et al.
·
Journal of Radiation Research
·
6
PDF
Clinical workload profile of medical physics professionals at particle therapy Centers: a National Survey in Japan
2024
·
Seiichi Ota
, Keisuke Yasui
, et al.
·
Journal of Radiation Research
·
4
PDF
Current status of the working environment of brachytherapy in Japan: a nationwide survey-based analysis focusing on radiotherapy technologists and medical physicists
2024
·
Toru Kojima
, Hiroyuki Okamoto
, et al.
·
Journal of Radiation Research
·
1
PDF
639. In Vivo Imaging of Lymph Node Metastasis with Telomerase-Specific Replication-Competent Adenovirus Containing Green Fluorescent Protein Gene
2006
·
Toru Kojima
, Hiroyuki Kishimoto
, et al.
·
Molecular Therapy
·
1
Three‐dimensional source position verification in image‐guided high‐dose‐rate brachytherapy using an XCT‐based gel dosimeter
2024
·
Miki Yonemura
, Hidenobu Tachibana
, et al.
·
Medical Physics
PDF
Supplementary Fig. S3 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer
2023
·
Dong Liu
, Toru Kojima
, et al.
PDF
Supplementary Figure 2 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
2023
·
Ryo Sakai
, Shunsuke Kagawa
, et al.
PDF
Supplementary Figure 1 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
2023
·
Ryo Sakai
, Shunsuke Kagawa
, et al.
Supplementary Figure 4 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
2023
·
Ryo Sakai
, Shunsuke Kagawa
, et al.
Supplementary Figure 3 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
2023
·
Ryo Sakai
, Shunsuke Kagawa
, et al.
PDF
Supplementary Figure Legends 1-4 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
2023
·
Ryo Sakai
, Shunsuke Kagawa
, et al.
PDF
Show more works
View as search
Works count:
52
Citation count:
556
H-index:
12
I10-index:
12
Year
Topic
Type
